EF
HAE icon

Empowered Funds’s Haemonetics HAE Stock Holding History

Empowered Funds’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,010
Closed -$282K – 2192
2026
Q1 		$282K Buy
+5,010
New +$326K ﹤0.01% 1846
2025
Q4 		– Sell
-5,777
Closed -$282K – 1374
2025
Q3 		$282K Buy
5,777
+1,444
+33% +$89.4K ﹤0.01% 1611
2025
Q2 		$323K Sell
4,333
-125
-3% -$8.28K ﹤0.01% 1474
2025
Q1 		$283K Buy
4,458
+372
+9% +$25.3K ﹤0.01% 1422
2024
Q4 		$319K Buy
+4,086
New +$328K ﹤0.01% 1350
2019
Q2 		– Sell
-16,598
Closed -$1.45M – 106
2019
Q1 		$1.45M Buy
16,598
+4,595
+38% +$418K 0.52% 72
2018
Q4 		$1.2M Buy
+12,003
New +$1.26M 0.51% 64

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empowered Funds's HAE Position: Q2 2026 in Review

Empowered Funds sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 5,010 shares — an estimated $282K sold.

Empowered Funds first reported a position in HAE in Q4 2018 and held it in 7 quarters. The position peaked at $1.45M in Q1 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Empowered Funds reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
  • Empowered Funds sold 5,010 Haemonetics shares in Q2 2026, an estimated $282K.
  • Empowered Funds first reported a position in Haemonetics in Q4 2018 and held it in 7 quarters.
  • Empowered Funds's Haemonetics position peaked at $1.45M in Q1 2019.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.